David Lyden is giving the Paget-Ewing award lecture! #MRS24 Metastasis Research Society

Excellent Patient Advocate session at ⁦Metastasis Research Society⁩ biennial Congress. Moderated by new MRS president ⁦Alana Welm⁩ ⁦Hillary Andrews, PhD⁩ and ⁦Janice Cowden⁩ provided early career researchers w/great info on how to find and work with advocates. #bcsm

Some of the Aussie Oz MRS crew enjoying sunny London ☀️😃 Thanks Metastasis Research Society #MRS24 eriksahailab and all board members for a fabulous #MRS24 meeting!!!!

Thanks to your generous support, we are proud to announce more than $10 million in research grants dedicated to advancing metastatic breast cancer (MBC) treatments and precision medicine. bit.ly/4ezy2Wn

That's a wrap for the MRS 20th Biennial Congress! Thank you to everyone who attended, to all of our speakers and to our awardees for making this a great congress! See you at the next one and stay tuned for info about upcoming Early Career panel webinar; safe travels everyone!

Thanks to everyone for participating in this panel and for the great discussions about research-patient partnerships at #MRS2024! We had many positive comments about this session. 😊

Yes, it's important to support each other through the disappointing failures of a career in academic science. Also yes, we must celebrate the rare successes along the way. But it's next level to have your institute actively downplay the lows and celebrate the highs along with you

Still not too late to register for our free webinar this week to hear Dr. Celina G. Kleer discuss how "A hybrid breast cancer/mesenchymal stromal cell population enhances metastasis". Sign-up here 👉 bit.ly/4cxZ4fk

Our new paper is out! PDX engraftment predicts early recurrence/death in patients with early stage TNBC (better than pCR). Thanks to the great collaborative group ⁦⁦Huntsman Cancer Institute⁩ - we’re working “towards” better precision care in breast cancer! ascopubs.org/doi/10.1200/PO…

This week is NBCC’s #ProjectLEAD – where advocates are learning to help ensure that the educated and trained patient voice is heard everywhere that decisions about breast cancer are made. It’s always great to see these empowered NBCC advocates!

Check out the outstanding work by Dave Lum and the PRR Huntsman Cancer Institute, specializing in PDX development and testing for many cancer types. A great resource!

Congratulations Minna Roh-Johnson !! Very well deserved! 😀

The MetARP blog posts are up! Major thanks to Metastasis Research Society and The Breast Cancer Research Foundation for the support. And thanks to the participants Joan Mancuso Janice Cowden Ann McBrien Kirstin Spencer Mogana Raj👩🏽‍🔬 Connor Purdy Nicole Barth Anna Salamero Boix Dr Angélica Santiago! See blogs here: theresasresearch.org/marp

It was such a pleasure to work with such a great group of researchers and advocates participating in MetARP. Their blogs are out now - check them out!

Come join us! We are hiring again for a new faculty member. The department is truly a supportive and collaborative group, where folks can (and have) develop an outstanding research program. Also feel free to DM if you have questions. utah.peopleadmin.com/postings/170290

Deadline September 10th!

We’re leading the way in research through the Artemis Project, which is an advocate led, innovative, mission-driven approach of strategic summits, catalytic workshops, research action plans, and collaborative efforts of various stakeholders. stopbreastcancer.org/what-we-do/res…

This weekend, hundreds of cyclists will ride 200+ miles from Logan to Jackson Hole in the LOTOJA race. This race has been raising funds for cancer research for years. Good luck to those riding this weekend! We are so grateful for your support! bit.ly/3Qke9s1

🚀 We’re thrilled to welcome Birgit Knoechel, MD, PhD to HCI & Hematological Malignancies Program as Section Head of Basic Science and Director of Translational Research in Pediatrics! She is a former physician-scientist at Dana-Farber/Boston Children’s Cancer Center.  Her

A new innovative tool developed by Alana Welm, Cindy Matsen, MD, & Christos Vaklavas, MD, forecasts the severity and likelihood of recurrence of triple-negative breast cancer. This advancement could revolutionize the way doctors treat TNBC. bit.ly/3TktMBf UofUSurgery